REGN vs. MRK
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or MRK.
Correlation
The correlation between REGN and MRK is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. MRK - Performance Comparison
Key characteristics
REGN:
-0.75
MRK:
-0.19
REGN:
-0.90
MRK:
-0.12
REGN:
0.88
MRK:
0.98
REGN:
-0.40
MRK:
-0.15
REGN:
-1.09
MRK:
-0.33
REGN:
15.08%
MRK:
11.98%
REGN:
21.92%
MRK:
21.10%
REGN:
-91.81%
MRK:
-68.62%
REGN:
-41.50%
MRK:
-24.05%
Fundamentals
REGN:
$81.32B
MRK:
$253.12B
REGN:
$40.40
MRK:
$4.78
REGN:
18.32
MRK:
20.93
REGN:
1.10
MRK:
0.07
REGN:
$13.85B
MRK:
$63.22B
REGN:
$11.69B
MRK:
$47.97B
REGN:
$4.83B
MRK:
$20.41B
Returns By Period
In the year-to-date period, REGN achieves a -19.96% return, which is significantly lower than MRK's -6.22% return. Over the past 10 years, REGN has underperformed MRK with an annualized return of 5.47%, while MRK has yielded a comparatively higher 9.17% annualized return.
REGN
-19.96%
-5.59%
-32.69%
-16.49%
13.38%
5.47%
MRK
-6.22%
3.91%
-22.12%
-2.96%
5.84%
9.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. MRK - Dividend Comparison
REGN has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 3.14%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% | 3.46% |
Drawdowns
REGN vs. MRK - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for REGN and MRK. For additional features, visit the drawdowns tool.
Volatility
REGN vs. MRK - Volatility Comparison
Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 7.59% compared to Merck & Co., Inc. (MRK) at 6.47%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities